tirzepatide principio activo Conoces Mounjaro (tirzepatida)? 💉 Es un agonista dual de receptores GLP-1 y GIP, inyectable semanal para el control de diabetes tipo 2 en adultos y reducción de peso en obesidad o sobrepeso Alerta Sanitaria Tirzepatida México 2026

Source: Coskun et al., The Lancet 2022 Phase 2 Results Phase 2 -- Obesity (NEJM 2023) NCT04881760 | Published: New England Journal of Medicine , 2023 (Jastreboff AM, et al.) This was the landmark Phase 2 trial that put retatrutide on the map

Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial

Because these medications suppress appetite, athletes who take them are susceptible to a condition called RED-S, or Relative Energy Deficiency in Sport. Basically, this is when your exercise output consistently outpaces caloric intake

Ozempic pens do not come with needles included

The medication quiets the noise long enough for you to see what is actually happening

For in utero stem cell procedures, the acute fetal complication rate is approximately 4.5%, with neonatal survival rates around 69.2%